Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-008498
Filing Date
2021-04-12
Accepted
2021-04-12 09:51:28
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 651354
2 ex31-1.htm EX-31.1 18437
3 ex31-2.htm EX-31.2 18371
4 ex32-1.htm EX-32.1 7557
  Complete submission text file 0001493152-21-008498.txt   4751979

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE brtx-20200630.xml EX-101.INS 896399
6 XBRL SCHEMA FILE brtx-20200630.xsd EX-101.SCH 55914
7 XBRL CALCULATION FILE brtx-20200630_cal.xml EX-101.CAL 64042
8 XBRL DEFINITION FILE brtx-20200630_def.xml EX-101.DEF 228113
9 XBRL LABEL FILE brtx-20200630_lab.xml EX-101.LAB 411676
10 XBRL PRESENTATION FILE brtx-20200630_pre.xml EX-101.PRE 332254
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 21819605
SIC: 8090 Services-Misc Health & Allied Services, NEC